Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Viveve Medical Inc    VIVE

VIVEVE MEDICAL INC

(VIVE)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/11/2019 02/12/2019 02/13/2019 02/14/2019 02/15/2019 Date
1.04(c) 1.06(c) 1.04(c) 1.05(c) 1.08(c) Last
117 400 211 536 70 746 138 129 127 197 Volume
-3.70% +1.92% -1.89% +0.96% +2.86% Change
More quotes
Financials (USD)
Sales 2018 18,4 M
EBIT 2018 -44,0 M
Net income 2018 -49,0 M
Debt 2018 -
Yield 2018 -
Sales 2019 19,7 M
EBIT 2019 -32,3 M
Net income 2019 -37,0 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 2,63x
Capi. / Sales2019 2,46x
Capitalization 48,4 M
More Financials
Company
Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three... 
More about the company
Surperformance© ratings of Viveve Medical Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VIVEVE MEDICAL INC
01/30VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Lis..
AQ
01/16VIVEVE MEDICAL, INC. : Results of Operations and Financial Condition, Costs Asso..
AQ
01/16Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 R..
GL
01/04VIVEVE MEDICAL : Completes Enrollment in LIBERATE-International Trial for Improv..
AQ
01/03Viveve Completes Enrollment in LIBERATE-International Trial for Improvement o..
GL
2018VIVEVE MEDICAL : Announces FDA Clearance to Advance II Clinical Study to Full En..
AQ
2018Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full En..
GL
2018VIVEVE MEDICAL : Announces Closing of Public Offering of Shares of Common Stock
AQ
2018VIVEVE MEDICAL : Announces Closing of Public Offering of Shares of Common Stock
AQ
2018VIVEVE MEDICAL, INC. : Entry into a Material Definitive Agreement, Other Events,..
AQ
More news
Analyst Recommendations on VIVEVE MEDICAL INC
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
02/14Widex, Sivantos win EU approval for $8.3 billion hearing aid merger
RE
02/13INTUITIVE SURGICAL : Johnson & Johnson to buy surgical robotics firm Auris for $..
RE
02/08GLOBAL MARKETS LIVE : Sony, L’Oreal, BB&T, Amazon…
01/30GLOBAL MARKETS LIVE : Alibaba, LVMH, Apple, Societe Generale…
01/30SIEMENS HEALTHINEERS : wants to extend gas turbine tie-up with China's SPIC
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart VIVEVE MEDICAL INC
Duration : Period :
Viveve Medical Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIVEVE MEDICAL INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 4,38 $
Spread / Average Target 305%
EPS Revisions
Managers
NameTitle
Scott C. Durbin Chief Executive Officer & Director
James G. Atkinson President & Chief Business Officer
Steven L. Basta Chairman
Marty Kerber Vice President-Operations
Jim B. Robbins Chief Financial & Accounting Officer
Sector and Competitors
1st jan.Capitalization (M$)
VIVEVE MEDICAL INC2.86%48
THERMO FISHER SCIENTIFIC12.82%101 647
DANAHER CORPORATION7.87%77 968
INTUITIVE SURGICAL14.53%62 797
BOSTON SCIENTIFIC CORPORATION13.21%55 366
ILLUMINA-0.04%44 074